Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced plans to present eight abstracts at an upcoming major conference in Europe, showcasing new data on its cannabidiol (CBD) epilepsy treatment. The survey, which the company will present at the 15th European Epilepsy Congress in Rome next week, found that 87% of caregivers reported …
Clinical Trial: CBD Dosing Reduces Daytime Fatigue Compared to Placebo
“Five-week administration of CBD, but not of placebo, resulted in improvements … [in] fatigue/vitality and psychological well-being,” investigators concluded. The post Clinical Trial: CBD Dosing Reduces Daytime Fatigue Compared to Placebo appeared first on NORML.
Study: Endometriosis Patients Report Quality of Life Improvements Following Cannabis Use
“Cannabis was rated as the most effective self-management strategy to reduce symptom intensity.” The post Study: Endometriosis Patients Report Quality of Life Improvements Following Cannabis Use appeared first on NORML.
Alabama judge considers revising order that’s stalled medical marijuana licensing
A Montgomery County Circuit Court judge is considering revising a temporary restraining order that has kept the issuance of medical marijuana business licenses in limbo. But what that change would entail is still unknown. Judge James Anderson on Tuesday heard arguments from attorneys representing the Alabama Medical Cannabis Commission and …